Search cutoffs
Search companies, layoffs, filings, signals, and visa data
Search companies, layoffs, filings, signals, and visa data
Search companies, layoffs, filings, signals, and visa data
Search companies, layoffs, filings, signals, and visa data
Search companies, layoffs, filings, signals, and visa data
Current report (Form 8-K) · Jun 2, 2026 · Other material event · Financial statements
NRX Pharmaceuticals, Inc.
8
Other material event
Jun 2, 2026
| ItemItem | Disclosure |
|---|---|
| Item 8.01 | Other events the company considers material |
| Item 9.01 | Financial statements and exhibits |
NRX Pharmaceuticals, Inc. filed this to release information to investors under Regulation FD — usually a press release, conference presentation, or other event the company considers important. Announces Proposed Public Offering of Common Stock WILMINGTON, Del. , June 2, 2026 (GLOBE NEWSWIRE) -- NRx Pharmaceuticals, Inc.
This filing reports Item 8.01 (other events the company considers material). These item codes often precede or accompany restructuring, leadership changes, or deals that can shift headcount.
NRX Pharmaceuticals, Inc. reported material events that can affect workforce planning. cutoffs surfaces the filing alongside WARN layoffs, H-1B activity, and company signals.
